3378 logo

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. Stock Price

SEHK:3378 Community·HK$3.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

3378 Share Price Performance

HK$24.16
6.96 (40.47%)
HK$24.16
6.96 (40.47%)
Price HK$24.16

3378 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks
0 Rewards

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. Key Details

CN¥2.2m

Revenue

CN¥0

Cost of Revenue

CN¥2.2m

Gross Profit

CN¥118.0m

Other Expenses

-CN¥115.8m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Mar 27, 2026
-0.85
100.00%
-5,267.39%
0%
View Full Analysis

About 3378

Founded
2014
Employees
55
CEO
Qixiang Li
WebsiteView website
www.hanxbio.com

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. develops and manufactures immunotherapies for cancer and autoimmune diseases. The company's products include antibody drugs, including monoclonal, bispecific, and antibody drug conjugates for immuno-oncology pathways. The company was incorporated in 2014 and is headquartered in Wuhan, China.

Recent 3378 News & Updates

Recent updates

No updates